The displacement of frataxin from the mitochondrial cristae correlates with abnormal respiratory supercomplexes formation and bioenergetic defects in cells of Friedreich ataxia patients
- 25 February 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (3), e21362
- https://doi.org/10.1096/fj.202000524rr
Abstract
Friedreich ataxia (FRDA) is a neurodegenerative disease resulting from a severe decrease of frataxin (FXN). Most patients carry a GAA repeat expansion in both alleles of the FXN gene, whereas a small fraction of them are compound heterozygous for the expansion and a point mutation in the other allele. FXN is involved in the mitochondrial biogenesis of the FeS‐clusters. Distinctive feature of FRDA patient cells is an impaired cellular respiration, likely due to a deficit of key redox cofactors working as electrons shuttles through the respiratory chain. However, a definite relationship between FXN levels, FeS‐clusters assembly dysregulation and bioenergetics failure has not been established. In this work, we performed a comparative analysis of the mitochondrial phenotype of cell lines from FRDA patients, either homozygous for the expansion or compound heterozygotes for the G130V mutation. We found that, in healthy cells, FXN and two key proteins of the FeS‐cluster assembly machinery are enriched in mitochondrial cristae, the dynamic subcompartment housing the respiratory chain. On the contrary, FXN widely redistributes to the matrix in FRDA cells with defects in respiratory supercomplexes assembly and altered respiratory function. We propose that this could be relevant for the early mitochondrial defects afflicting FRDA cells and that perturbation of mitochondrial morphodynamics could in turn be critical in terms of disease mechanisms.Keywords
Funding Information
- Università degli Studi di Padova
- Università degli Studi di Padova
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Fondazione Città della Speranza
This publication has 74 references indexed in Scilit:
- Compound heterozygous FXN mutations and clinical outcome in friedreich ataxiaAnnals of Neurology, 2015
- Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxiaMovement Disorders, 2011
- Friedreich's ataxia: Pathology, pathogenesis, and molecular geneticsJournal of the Neurological Sciences, 2011
- Friedreich ataxia: The clinical pictureZeitschrift für Neurologie, 2009
- Frataxin gene point mutations in Italian Friedreich ataxia patientsneurogenetics, 2007
- Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patientsHuman Genetics, 2000
- Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotesAnnals of Neurology, 1999
- Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial MembranesHuman Molecular Genetics, 1997
- Clinical and Genetic Abnormalities in Patients with Friedreich's AtaxiaThe New England Journal of Medicine, 1996
- Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat ExpansionScience, 1996